David A. Goldfarb

University of British Columbia

Papers

1

Total Citations

11

H-Index

1

About

David A. Goldfarb is a clinical microbiologist and infectious disease researcher whose work has been pivotal in advancing diagnostic strategies during the COVID-19 pandemic. His primary research areas include pediatric infectious diseases, point-of-care diagnostics, and the development of scalable, resource-efficient testing methods for emerging pathogens. Goldfarb’s major contribution lies in optimizing high-throughput molecular detection of SARS-CoV-2, notably through his 2023 study on extraction-free clinical detection of the virus from self-collected saline gargle samples using the Hamilton STARlet liquid handler. This work, which has garnered 11 citations, addressed critical shortages in reagents and staffing by streamlining PCR workflows, enabling laboratories to process large volumes of tests rapidly and safely. By validating the use of non-invasive saline gargle samples, Goldfarb helped reduce reliance on nasopharyngeal swabs and complex extraction steps, making testing more accessible and less burdensome for patients. His research has had a tangible impact on pandemic response, offering a practical, low-cost solution that has been adopted in clinical settings to sustain testing capacity during surges. Goldfarb’s innovative approach to clinical diagnostics continues to shape best practices for outbreak management and public health preparedness.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Extraction-free clinical detection of SARS-CoV-2 virus from saline gargle samples using Hamilton STARlet liquid handler
11 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of British Columbia

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago